title: Biology-driven cancer drug development: back to the future.
abstract: Most of the significant recent advances in cancer treatment have been based on the great strides that have been made in our understanding of the underlying biology of the disease. Nevertheless, the exploitation of biological insight in the oncology clinic has been haphazard and we believe that this needs to be enhanced and optimized if patients are to receive maximum benefit. Here, we discuss how research has driven cancer drug development in the past and describe how recent advances in biology, technology, our conceptual understanding of cell networks and removal of some roadblocks may facilitate therapeutic advances in the (hopefully) near future.
authors.affiliation: The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK. chris.lord@icr.ac.uk
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Lord
authors.forename: Alan
authors.initials: A
authors.lastname: Ashworth
mesh_terms: D016588:Anticarcinogenic Agents / Q000494:pharmacology*; D015195:Drug Design; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D012106:Research; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology
chemical_list: D016588:Anticarcinogenic Agents
references.citation: Science. 2001 Aug 3;293(5531):876-80
references.pmid: 11423618
references.citation: Cancer Cell. 2005 Feb;7(2):129-41
references.pmid: 15710326
references.citation: Drugs. 2007;67(5):805-20
references.pmid: 17385949
references.citation: N Engl J Med. 2002 Aug 15;347(7):481-7
references.pmid: 12181402
references.citation: Cell. 1984 Jan;36(1):93-9
references.pmid: 6319012
references.citation: Nature. 2009 Nov 5;462(7269):108-12
references.pmid: 19847166
references.citation: Nature. 2008 Feb 28;451(7182):1111-5
references.pmid: 18264088
references.citation: Science. 1988 Nov 11;242(4880):933-5
references.pmid: 3263702
references.citation: N Engl J Med. 2009 Sep 17;361(12):1164-72
references.pmid: 19726763
references.citation: Science. 1956 Feb 24;123(3191):309-14
references.pmid: 13298683
references.citation: Science. 2000 Sep 15;289(5486):1938-42
references.pmid: 10988075
references.citation: Nature. 2010 Jan 28;463(7280):501-6
references.pmid: 20072125
references.citation: Proc Natl Acad Sci U S A. 1981 Mar;78(3):1552-6
references.pmid: 6262813
references.citation: Br J Haematol. 2000 Jul;110(1):2-11
references.pmid: 10930974
references.citation: Nature. 2009 Dec 24;462(7276):1005-10
references.pmid: 20033038
references.citation: Nat Genet. 2008 Jun;40(6):722-9
references.pmid: 18438408
references.citation: Science. 1964 Jun 5;144(3623):1229-31
references.pmid: 14150328
references.citation: N Engl J Med. 2009 Sep 17;361(12):1173-8
references.pmid: 19726761
references.citation: Hematol Oncol Clin North Am. 2009 Jun;23(3):529-45, ix
references.pmid: 19464601
references.citation: Cancer Res. 1970 Aug;30(8):2213-22
references.pmid: 4318922
references.citation: Nat Rev Drug Discov. 2002 Feb;1(2):153-61
references.pmid: 12120097
references.citation: JAMA. 1984 May 4;251(17):2255-61
references.pmid: 6368885
references.citation: JAMA. 2006 Sep 27;296(12):1518-20
references.pmid: 17003400
references.citation: Blood. 2008 Dec 15;112(13):4808-17
references.pmid: 19064740
references.citation: Nature. 2008 Mar 13;452(7184):230-3
references.pmid: 18337823
references.citation: Nature. 1973 Jun 1;243(5405):290-3
references.pmid: 4126434
references.citation: J Biol Chem. 2002 Aug 30;277(35):32214-9
references.pmid: 12077114
references.citation: Nature. 2010 Jan 14;463(7278):191-6
references.pmid: 20016485
references.citation: Cancer Cell. 2004 May;5(5):501-12
references.pmid: 15144957
references.citation: Clin Cancer Res. 1997 Dec;3(12 Pt 2):2696-702
references.pmid: 10068276
references.citation: Science. 1990 Feb 16;247(4944):824-30
references.pmid: 2406902
references.citation: Nature. 2005 Apr 14;434(7035):917-21
references.pmid: 15829967
references.citation: N Engl J Med. 2009 Jul 9;361(2):123-34
references.pmid: 19553641
references.citation: Nature. 1982 Dec 23;300(5894):765-7
references.pmid: 6960256
references.citation: Nature. 1980 Oct 30;287(5785):795-801
references.pmid: 6776413
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: Nat Rev Cancer. 2009 Jul;9(7):463-75
references.pmid: 19536107
references.citation: Cell. 1984 Jul;37(3):1035-42
references.pmid: 6204766
references.citation: Cell. 2009 Mar 6;136(5):823-37
references.pmid: 19269363
references.citation: Hematol Oncol Clin North Am. 2004 Jun;18(3):545-68, vii-viii
references.pmid: 15271392
references.citation: Cell. 1980 Dec;22(3):777-85
references.pmid: 6257398
references.citation: Cell. 2007 Jun 15;129(6):1065-79
references.pmid: 17574021
references.citation: N Engl J Med. 2009 Oct 8;361(15):1475-85
references.pmid: 19812404
references.citation: Nat Rev Mol Cell Biol. 2009 Jul;10(7):478-87
references.pmid: 19546858
references.citation: Nature. 2010 Jan 14;463(7278):184-90
references.pmid: 20016488
references.citation: Cell. 2009 May 29;137(5):821-34
references.pmid: 19490892
references.citation: Br J Cancer. 1971 Jun;25(2):270-5
references.pmid: 5115829
references.citation: Ann N Y Acad Sci. 1954 Dec 6;60(2):195-9
references.pmid: 14350523
references.citation: Nat Rev Cancer. 2009 Jan;9(1):28-39
references.pmid: 19104514
references.citation: Blood. 2000 Nov 15;96(10):3343-56
references.pmid: 11071626
references.citation: Nature. 1990 Mar 15;344(6263):251-3
references.pmid: 2179728
references.citation: Nat Rev Cancer. 2008 Jun;8(6):473-80
references.pmid: 18469827
references.citation: Nat Rev Cancer. 2008 Nov;8(11):875-9
references.pmid: 18948997
references.citation: Cell. 2009 May 29;137(5):835-48
references.pmid: 19490893
references.citation: Nature. 2008 Sep 25;455(7212):547-51
references.pmid: 18794900
references.citation: Cell. 2010 Jan 22;140(2):209-21
references.pmid: 20141835
references.citation: Nat Biotechnol. 2010 Jan;28(1):83-9
references.pmid: 20010810
references.citation: Nat Rev Drug Discov. 2007 Jul;6(7):556-68
references.pmid: 17599085
references.citation: Nat Rev Cancer. 2005 Sep;5(9):689-98
references.pmid: 16110319
references.citation: Nat Med. 1996 May;2(5):561-6
references.pmid: 8616716
references.citation: Blood. 1958 Dec;13(12):1126-48
references.pmid: 13596417
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: N Engl J Med. 1948 Jun 3;238(23):787-93
references.pmid: 18860765
references.citation: Cancer Cell. 2008 Jun;13(6):472-82
references.pmid: 18538731
references.citation: Genes Dev. 2008 Jun 1;22(11):1427-38
references.pmid: 18519635
references.citation: Dev Cell. 2008 Dec;15(6):801-12
references.pmid: 19081070
references.citation: N Engl J Med. 2001 Apr 5;344(14):1031-7
references.pmid: 11287972
references.citation: Nature. 2007 Feb 22;445(7130):851-7
references.pmid: 17314971
references.citation: J Med Chem. 2004 Dec 30;47(27):6658-61
references.pmid: 15615512
references.citation: Nature. 2009 Oct 8;461(7265):809-13
references.pmid: 19812674
references.citation: Cancer Cell. 2009 Oct 6;16(4):281-94
references.pmid: 19800574
references.citation: J Virol. 1990 Jan;64(1):61-8
references.pmid: 2152834
references.citation: Cancer Res. 1963 Sep;23:1390-427
references.pmid: 14070392
references.citation: Nature. 1985 Jun 13-19;315(6020):550-4
references.pmid: 2989692